« Back to Record
Citation APA

Socié, G., Gard, P., Medeghri, Z., Lehert, P., Lai, C., Corn, T., Vernant, J. P., Vigouroux, S., Yakoub-Agha, I., Bay, J. O., Fürst, S., Bilger, K., Suarez, F., Michallet, M., & Bron, D. (2017). A phase 3 randomized trial comparing inolimomab vs usual care in steroid-resistant acute GVHD. Blood, 129(5), 643-649. doi:10.1182/blood-2016-09-738625


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/249792

Socié, G., Gard, P., Medeghri, Z., Lehert, P., Lai, C., Corn, T., Vernant, J. P., Vigouroux, S., Yakoub-Agha, I., Bay, J. O., Fürst, S., Bilger, K., Suarez, F., Michallet, M., & Bron, D. (2017). A phase 3 randomized trial comparing inolimomab vs usual care in steroid-resistant acute GVHD. Blood, 129(5), 643-649. doi:10.1182/blood-2016-09-738625